Gerresheimer AG Reports Robust Q4 Results
Düsseldorf, Germany – February 22, 2023 – Gerresheimer AG, a leading provider of specialty glass containers and pharmaceutical packaging solutions, today announced its results for the fourth quarter (Q4) of the 2022 financial year.
According to the company’s report, Gerresheimer AG delivered a strong performance in Q4, with revenue increasing by 12.1% to €453 million compared to the same period in the previous year. This growth was driven by higher sales volumes, particularly in the company’s Pharmaceutical Systems and Life Sciences segments, as well as positive pricing effects.
The company’s operating profit (EBIT) for Q4 2022 rose by 19.4% to €53.1 million, underscoring the company’s successful operational performance. Gerresheimer AG’s EBIT margin improved by 140 basis points to 11.7%, demonstrating the company’s ability to maintain profitability despite rising costs and supply chain disruptions.
Gerresheimer’s CEO, Timo Herzberger, highlighted the company’s strong performance: "We are pleased with our Q4 results, which reflect our successful execution and diversification strategy. Our team has done an outstanding job in navigating the challenges in the market, and I am proud of our ability to deliver a strong performance."
The company’s Pharmaceutical Systems segment, which includes the manufacturing of pharmaceutical primary packaging, reported revenue growth of 15.4% to €242 million in Q4 2022. This increase was primarily driven by higher sales volumes and price increases. The Life Sciences segment, which offers products for the biotechnology and pharmaceutical industries, achieved revenue growth of 9.3% to €121 million.
In contrast, the company’s Consumer Products segment, which includes the production of specialty glass packaging for the cosmetics and luxury goods industries, reported a lower revenue of €90 million, down 6.2% from the same period in the previous year. This decline was primarily due to weaker demand from certain Asian markets and the negative impact of COVID-19 restrictions on the luxury goods industry.
Gerresheimer AG’s Board of Directors has approved the company’s financial statements for 2022, which confirm that the company has made significant progress in its strategic initiatives. The company is on track to achieve its medium-term targets, including a growth corridor of 3-5% revenue growth and a European operating margin of 12-14%.
"We are confident that our strategy will continue to generate long-term value for our shareholders and stakeholders," added Herzberger. "We remain committed to our focus on sustainability, innovation, and customer-centricity, and we are excited about the opportunities ahead."
Gerresheimer AG is one of the leading global players in the specialty glass and pharmaceutical packaging market, with a presence in over 31 countries worldwide. The company’s products and solutions are used by many well-known brands in various industries, including pharmaceuticals, cosmetics, and luxury goods.
